FindTrial
Sign In

Utility of testing Gluten immunogenic peptide levels in urine for checking compliance to diet in children with celiac disease.

Urinary Gluten Immunogenic Peptide as a biomarker for monitoring adherence to diet in children with Celiac disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072256
Enrollment
30
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Gluten free diet: Testing levels of Urinary Gluten Immunogenic Peptide before and after initiating Gluten Free Diet in children diagnosed with Celiac disease.

Sponsors

Dr Shreya Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children newly diagnosed with Celiac disease between 1-12 years age, presenting to the Department of Pediatrics. Diagnosis of CD will be made as per ESPGHAN 2020 criteria.

Exclusion criteria

Exclusion criteria: 1.Patients with known chronic inflammatory bowel disease 2.Patients with a history of necrotizing enterocolitis and known short bowel syndrome 3.Patients with known chronic kidney disease

Design outcomes

Primary

MeasureTime frame
Change in the urinary GIP levels from baseline after institution of gluten free dietTimepoint: At 1 week and at 1 month of starting gluten free diet—

Secondary

MeasureTime frame
Association between Urinary GIP levels and anti tTG-IgA levels after 1 month of gluten free dietTimepoint: At 1 month of gluten free diet—

Countries

India

Contacts

Public ContactDr Seema Kapoor

Maulana Azad Medical College

drseemakapoor@gmail.com9868846606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026